Cargando…
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219312/ https://www.ncbi.nlm.nih.gov/pubmed/34171435 http://dx.doi.org/10.1016/j.jhep.2021.06.014 |
| _version_ | 1783710900462551040 |
|---|---|
| author | Clayton-Chubb, Daniel Schneider, Daniel Freeman, Elliot Kemp, William Roberts, Stuart K. |
| author_facet | Clayton-Chubb, Daniel Schneider, Daniel Freeman, Elliot Kemp, William Roberts, Stuart K. |
| author_sort | Clayton-Chubb, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8219312 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Association for the Study of the Liver. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82193122021-06-23 Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine Clayton-Chubb, Daniel Schneider, Daniel Freeman, Elliot Kemp, William Roberts, Stuart K. J Hepatol Letter to the Editor European Association for the Study of the Liver. Published by Elsevier B.V. 2021-11 2021-06-22 /pmc/articles/PMC8219312/ /pubmed/34171435 http://dx.doi.org/10.1016/j.jhep.2021.06.014 Text en © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Clayton-Chubb, Daniel Schneider, Daniel Freeman, Elliot Kemp, William Roberts, Stuart K. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine |
| title | Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine |
| title_full | Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine |
| title_fullStr | Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine |
| title_full_unstemmed | Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine |
| title_short | Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine |
| title_sort | autoimmune hepatitis developing after the chadox1 ncov-19 (oxford-astrazeneca) vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219312/ https://www.ncbi.nlm.nih.gov/pubmed/34171435 http://dx.doi.org/10.1016/j.jhep.2021.06.014 |
| work_keys_str_mv | AT claytonchubbdaniel autoimmunehepatitisdevelopingafterthechadox1ncov19oxfordastrazenecavaccine AT schneiderdaniel autoimmunehepatitisdevelopingafterthechadox1ncov19oxfordastrazenecavaccine AT freemanelliot autoimmunehepatitisdevelopingafterthechadox1ncov19oxfordastrazenecavaccine AT kempwilliam autoimmunehepatitisdevelopingafterthechadox1ncov19oxfordastrazenecavaccine AT robertsstuartk autoimmunehepatitisdevelopingafterthechadox1ncov19oxfordastrazenecavaccine |